First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Even before the COVID-19 outbreak, there had been a rise in requests for mental health evaluations on workers' compensation claims – what i
Each year Mitchell celebrates one of its partners through the "mPower Award" highlighting innovative and transformational initiatives taken on in t
On this episode of Mitchell’s mPower podcast series, Product Management Director Chris Williamson joins our host, Shelley Callahan, senior director
The stories Natasha Charleston heard were haunting.
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
For more than six decades, innovators have attempted to unlock the full potential of artificial intelligence (AI).